-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Capricor Therapeutics, Inc. annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2024.
- Capricor Therapeutics, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2024 was -$1.27M, a 130% decline year-over-year.
- Capricor Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$40M, a 56.3% decline from 2023.
- Capricor Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$25.6M, a 621% decline from 2022.
- Capricor Therapeutics, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was $4.92M.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)